title: Generic clopidogrel: time to substitute?
authors.affiliation: Duke University Medical Center, Durham, North Carolina 27705, USA. jacob.doll@duke.edu
authors.forename: Jacob
authors.initials: J
authors.lastname: Doll
authors.forename: Emily
authors.initials: E
authors.lastname: Zeitler
authors.forename: Richard
authors.initials: R
authors.lastname: Becker
mesh_terms: D002626:Chemistry, Pharmaceutical; D000077144:Clopidogrel; D017046:Cost Savings; D017277:Drug Approval; D016527:Drug Costs; D057915:Drug Substitution; D016568:Drugs, Generic / Q000191:economics / Q000493:pharmacokinetics*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000191:economics / Q000493:pharmacokinetics*; D010818:Practice Patterns, Physicians'; D013810:Therapeutic Equivalency; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000191:economics / Q000493:pharmacokinetics; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine